303085-53-2

Basic information

• Product Name: 3-Pyridazinecarboxaldehyde, 6-chloro- (9CI)
• Synonyms: 3-Pyridazinecarboxaldehyde, 6-chloro- (9CI);3-PYRIDAZINECARBOXYALDEHYDE,6-CHLORO;6-Chloro-3-pyridazinecarboxaldehyde;3-Chloro-6-formylpyridazine;6-chloropyridazine-3-carbaldehyde;6-Chloro-3-formylpyridazine;6-Chloropyridazine-3-carboxaldehyde;6-chloro-3-pyridazinecarboxyaldehyde
• CAS NO: 303085-53-2
• Molecular Formula: C₅H₃ClN₂O
• Molecular Weight: 142.54312
• Product Categories: HALIDE;ALDEHYDE;Building Blocks;Pyridazine
• Mol File: 303085-53-2.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 335℃
• Flash Point: 156℃
• Appearance: /
• Density: 1.432
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.601
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: -0.81±0.10(Predicted)
• CAS DataBase Reference: 3-Pyridazinecarboxaldehyde, 6-chloro- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Pyridazinecarboxaldehyde, 6-chloro- (9CI)(303085-53-2)
• EPA Substance Registry System: 3-Pyridazinecarboxaldehyde, 6-chloro- (9CI)(303085-53-2)

Safety Data

• Hazardous Substances Data: 303085-53-2(Hazardous Substances Data)

Usage

Uses

6-chloropyridazine-3-carbaldehyde is a useful reactant for organic synthesis.

InChI:InChI=1/C5H3ClN2O/c6-5-2-1-4(3-9)7-8-5/h1-3H

Upstream product

• 75680-92-1 6-chloro-3-pyridazinecarboxylic acid ethyl ester 
• 5096-73-1 6-chloro-pyridazine-3-carboxylic acid 
• 65202-50-8 methyl 6-chloro-3-pyridazinecarboxylate 
• 223445-04-3 3-chloro-6-vinylpyridazine 

Downstream Products

• 5096-73-1 6-chloro-pyridazine-3-carboxylic acid 
• 1011487-94-7 (6-chloropyridazin-3-yl)methanol 
• 1706439-95-3 3-chloro-6-(difluoromethyl)pyridazine 

Relevant articles and documents

TETRAHYDROPYRAZOLO-PYRAZINYL-DIHYDROIMIDAZOLONE OR TETRAHYDROPYRAZOLO-PYRIDINYL-DIHYDROIMIDAZOLONE COMPOUNDS AND METHODS OF USING SAME

The application relates to a compound of Formula (I) : or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of GLP-1 receptor, a pharmaceutical composition comprising a compound of Formula (I), and a method of treating or preventing a disease in which GLP-1 receptor plays a role.

SULFONE PYRIDINE ALKYL AMIDE-SUBSTITUTED HETEROARYL COMPOUNDS

Compounds having the following formula I: or a stereoisomer or pharmaceutically-acceptable salt thereof, where R1, R2, R3, R4, and R5 are as defined herein, are useful in the modulation of IL-12, IL-23 and/or IFNα, by acting on Tyk-2 to cause signal transduction inhibition.

OXAZOLIDINONE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS

A compound of the formula (I), or a pharmaceutically-acceptable salt, or in-vivo hydrolysable ester thereof: (I)wherein in (I) C is for example wherein A and B are independently selected from i) ii) and m is 1 or 2;R2b and R6b, R2a and R6a, R3a and R5a, are for example selected from H, F, OMe and Me;R2b' and R6b', R2a' and R6a', R3a', R5a' are for example selected from H, OMe and Me;R1a is for example optionally substituted (1-10C)alkyl;R1b is for example selected from NR5C(=W)R4, a) , or b) wherein HET-1 is for example isoxazolyl and HET-2 is for example triazolyl or tetrazolyl.Methods for making compounds of the formula (I), compositions containing them and their use as antibacterial agents are also described.